Feasibility and Safety of the Airway Exchange Broncholaryngoscope (AEBLScope)
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Jun 19, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new medical tool called the Airway Exchange Broncholaryngoscope (AEBLScope). This device is designed to help doctors safely and easily change tracheostomy tubes, which are tubes inserted into the windpipe to help people breathe. The study focuses on adults who have had a tracheostomy tube for more than a month and come to the clinic regularly for tube changes. The goal is to see if using this new tool is safe and practical during these routine procedures.
To be part of the study, participants need to be adults who depend on a tracheostomy tube but do not currently need extra oxygen or breathing machines. They must have had at least one previous tube change and be scheduled for a regular tube replacement in a doctor’s office. People with active lung infections, certain lung diseases, very small airway tubes, or who cannot be intubated through the mouth will not be eligible. Participants who join can expect to have their tracheostomy tube changed using this new device while doctors carefully watch for safety and ease of use. This study is not yet recruiting participants, but it aims to improve the experience and safety of tracheostomy care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years
- • Chronically (\>1 month) tracheostomy-dependent outpatients
- • Currently not requiring ventilatory or supplemental oxygen support
- • Have undergone at least one prior tracheostomy tube exchange
- • Scheduled for routine in-office tracheostomy tube exchange
- • Able to provide informed consent
- Exclusion Criteria:
- • Active respiratory infection
- • Patients with airway tubes having an inner diameter less than 6.0 mm
- • Patients with preexisting pulmonary conditions, including chronic obstructive pulmonary disease (COPD), restrictive lung disease, untreated pneumonia, or acute respiratory distress syndrome (ARDS)
- • Patients who are tracheostomy-dependent but cannot be orotracheally intubated.
- • Patients unable to provide informed consent and who have no legally authorized representative.
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Karla O'Dell, M.D.
Principal Investigator
Univserity of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported